USDA has approved Suvaxyn PCV2 vaccine for flexible dosing and for use in pigs as young as three weeks of age. The porcine circovirus type 2 vaccine from Fort Dodge Animal Health has been available since mid-2006.

The vaccine is designed to allow the most appropriate vaccination protocol for specific production systems. The new USDA approval allows vaccination in a single 2-mL dose in pigs three weeks of age or older or in two 1-mL doses, with the first dose at three weeks of age or older and the second dose three weeks later.

“We know many factors affect the success of any vaccination program,” says Dan Ellsworth, senior product manager, Fort Dodge Animal Health. “Changes in pig flow, viral load, maternal antibody levels and many other elements in day-to-day pork production can hamper a vaccine’s protection of individual pigs. By allowing pork producers and veterinarians to determine both timing and number of doses with Suvaxyn PCV2, they have significantly more control over vaccine-triggered immunity.

Suvaxyn PCV2 vaccine aids in the prevention of PCV2 viremia and control of lymphoid (immune system) depletion caused by PCV2. Data approved by the USDA indicate Suvaxyn PCV2 vaccine provides four months of protection against PCVAD.

For more information, see

Source: Fort Dodge Animal Health